UBS Group
PEPL

UBS Group’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

UBS Group’s Portfolio PEPL Stock Details PEPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,197
Closed -$12.2K – 10848
2022
Q4 		$12.2K Hold
1,197
– – ﹤0.01% 8305
2022
Q3 		$12K Hold
1,197
– – ﹤0.01% 8213
2022
Q2 		$12K Buy
1,197
+1,192
+23,840% +$11.8K ﹤0.01% 7707
2022
Q1 		$0 Buy
+5
New +$49 ﹤0.01% 11146

Other funds holding PEPL

RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCM
Robinson Capital Management Grosse Pointe Farms, Michigan $239M AUM 0.62% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

UBS Group's PEPL Position: Q1 2023 in Review

UBS Group sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2023, closing a stake of 1,197 shares — an estimated $12.2K sold.

UBS Group first reported a position in PEPL in Q1 2022 and held it in 4 quarters. The position peaked at $12.2K in Q4 2022. 15 funds tracked by Wall St. Rank hold PEPL as of Q1 2023.

  • UBS Group reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 1,197 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2023, an estimated $12.2K.
  • UBS Group first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q1 2022 and held it in 4 quarters.
  • UBS Group's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $12.2K in Q4 2022.
  • 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.